🖼
Figure 2 — Monoclonal Antibodies as a Therapeutic Strategy against Multidrug-Resistant Bact
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-983c1e5c-f3cb-4090-afda-7d4346
Figure 2Figure 2
Multifaceted mechanisms of mAbs against bacterial infections. This figure illustrates the complex mechanisms through which mAbs counteract bacterial infections. ( A ) Highlights the neutralization or inhibition of bacterial virulence factors by mAbs, mitigating their pathogenic effects. ( B ) The process of mAbs blocking receptor-mediated adhesion is depicted, preventing bacterial adherence to host cells and hindering the progression of infection. ( C ) Portrays the Antibody–Antibiotic Conjugate (ADC) strategy, where mAbs conjugated with antibiotics enhance the precision and effectiveness of bacterial targeting and elimination. ( D ) Focuses on the role of mAbs in inhibiting or disrupting biofilm formation, a primary bacterial defense mechanism, facilitating bacterial clearance. ( E ) Illustrates the mAb-mediated NETosis/opsonophagocytosis pathway, promoting bacterial clearance through the facilitation of neutrophil extracellular traps (NETs) and enhanced phagocytosis. ( F ) Delineates
▸Metadata
| pmid | 983c1e5c-f3cb-4090-afda-7d4346861ce5 |
| caption | Multifaceted mechanisms of mAbs against bacterial infections. This figure illustrates the complex mechanisms through which mAbs counteract bacterial infections. ( A ) Highlights the neutralization or |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC10890110/bin/life-14-00246-g002.jpg |
| paper_title | Monoclonal Antibodies as a Therapeutic Strategy against Multidrug-Resistant Bacterial Infections in a Post-COVID-19 Era. |
| figure_label | Figure 2 |
| figure_number | 2 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.